NCT00197223View on ClinicalTrials.gov

Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

6,213

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

May 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza vaccine

Trial Locations (1)

500 03

GSK Investigational Site, Hradec Králové

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY